New Derivative Lawsuit Is FIled in Delaware Over Kidney Drug Developer Share Price Drop
Misrepresentations made in SEC filings and communications with investors, the newest complaint alleges, led to Tricida shares dropping from more than $26 to $4.37 between July and…